INDV.L

Indivior Plc
Indivior PLC - Board Committee Changes
10th May 2024, 06:00
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 8838N
Indivior PLC
10 May 2024
 

Indivior PLC - Board Committee Changes

 

Slough, UK and Richmond, VA, May 10, 2024 - Indivior PLC announces that Dr. David Wheadon, who will join the Board as an Independent Non-Executive Director on June 1, 2024, has been appointed as a member of the Nomination, Remuneration and Science Committees also with effect from June 1, 2024.

 

Furthermore, in order to comply with Nasdaq's listing rule that requires the Nomination Committee be comprised solely of Independent Directors, Jerome Lande has advised the Board that he will step down as a member of the Nomination Committee with effect from May 31, 2024. Mr. Lande is a Representative Director of Scopia Capital Management LP, who are a significant shareholder of the Group.

 

Following these changes, the membership of the Nomination, Remuneration and Science Committees will be as follows:

 

Nomination Committee

Graham Hetherington (Chair)

Peter Bains

Joanna Le Couilliard

Dr. Keith Humphreys

Barbara Ryan

Mark Stejbach

Juliet Thompson

Dr. David Wheadon

 

Remuneration Committee

Joanna Le Couilliard (Chair)

Peter Bains

Graham Hetherington

Barbara Ryan

Dr. David Wheadon

 

Science Committee

Peter Bains (Chair)

Dr. Keith Humphreys

Barbara Ryan

Mark Stejbach

Dr. David Wheadon

 

This announcement is made in accordance with Listing Rule 9.6.11.

 

Kathryn Hudson

Company Secretary

 

 

Indivior PLC's Legal Entity Identifier code is 213800V3NCQTY7IED471.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAKKLFBZELLBBQ]]>
TwitterFacebookLinkedIn